Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 21, 2004Annals of Neurology

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKevin St. P. McNaughtHarvard UniversityDPDaniel P. PerlUniforABAnna‐Liisa BrownellMassachusetts General Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McNaught et al. (2004) studied this question.

synapsesocial.com/papers/6a7e2bbe37ea5212f5c76597https://doi.org/10.1002/ana.20186
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease1997 · 8,363 citations
  2. 2Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes2003 · 322 citations
  3. 3Thrombin-Induced Microglial Activation Produces Degeneration of Nigral Dopaminergic NeuronsIn Vivo2003 · 165 citations
  4. 4Proteasome inhibition causes nigral degeneration with inclusion bodies in rats2002 · 276 citations
  5. 5Molecular Pathways of Neurodegeneration in Parkinson's Disease2003 · 1,674 citations